New asthma inhaler tested in teens: early safety check

NCT ID NCT07065331

Completed Symptom relief Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a single inhaled dose of a new drug called AZD8630 in 10 teenagers with asthma. The main goal was to see how the drug moves through the body and to check for any safety issues. Participants used a dry powder inhaler and were monitored for side effects and immune reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

Research Site

Bakersfield, California, 93301, United States
Research Site

Miami Lakes, Florida, 33014, United States
Research Site

Lafayette, Louisiana, 70508, United States
Research Site

Raleigh, North Carolina, 27607, United States
Research Site

Toledo, Ohio, 43617, United States
Research Site

Oklahoma City, Oklahoma, 73120, United States
Research Site

Spartanburg, South Carolina, 29303, United States
Research Site

Boerne, Texas, 78006, United States
Research Site

Salt Lake City, Utah, 84107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.